BISMUTH SODIUM TRIGLYCOLLAMATE

US Previously Marketed

First approved in 1946

Details

Stereochemistry	ACHIRAL
Molecular Formula	C6H7BiNO7.3C6H7NO6.7Na
Molecular Weight	1142.3997
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of BISMUTH SODIUM TRIGLYCOLLAMATE

Structure Search

SMILES

[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC([O-])=O.[O-]C(=O)C[NH+](CC([O-])=O)CC([O-])=O.[O-]C(=O)C[NH+](CC([O-])=O)CC([O-])=O.[O-]C(=O)C[NH+](CC([O-])=O)CC(=O)O[Bi]=O

InChI

InChIKey=HCMDBCQMTCRYHB-UHFFFAOYSA-F

InChI=1S/4C6H9NO6.Bi.7Na.O/c4*8-4(9)1-7(2-5(10)11)3-6(12)13;;;;;;;;;/h4*1-3H2,(H,8,9)(H,10,11)(H,12,13);;;;;;;;;/q;;;;8*+1;/p-8

HIDE SMILES / InChI

Molecular Formula	C6H7BiNO7
Molecular Weight	414.1027
Charge	-1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Na
Molecular Weight	22.98976928
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C6H7NO6
Molecular Weight	189.1229
Charge	-2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.drugfuture.com/chemdata/bismuth-sodium-triglycollamate.html | https://www.ncbi.nlm.nih.gov/pubmed/20269094

BISMUTH SODIUM TRIGLYCOLLAMATE, a bismuth compound, is a lupus erythematosus suppressant.

Approval Year

PubMed

Title	Date	PubMed
Treatment of resistant verruca vulgaris with bismuth sodium triglycollamate.	1962-08	15445818
Chronic resistant otitis media treated with oral bismuth sodium triglycollamate.	1962-07	13869557
Inefficacy of sodium bismuth triglycollamate in the treatment of warts.	1958-07	13560716
Bistrimate (sodium bismuth triglycollamate) administered by mouth in the treatment of chronic discoid lupus erythematosus preliminary report.	1947-09	20269094
Disseminated lupus erythematosus treated with sodium bismuth triglycollamate (bistrimate tablets).	1947-06	20247767

Sample Use Guides

In Vivo Use Guide

1-2 tablets (75-150 mg of metallic bismuth) three times daily for as long as 26 week.

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:47:26 GMT 2025` Edited by `admin` on `Mon Mar 31 17:47:26 GMT 2025`
Record UNII	X9A8P4D3IF
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BISMUTH SODIUM TRIGLYCOLLAMATE

Common Name

English

BISMUTH SODIUM TRIGLYCOLLAMATE [MI]

Preferred Name

English

Code System Code Type Description

EVMPD

SUB33748